Plasma Therapy Global Market Report 2025

Description

Plasma therapy involves a treatment method that supplements deficient proteins, aiding individuals in leading healthier and more productive lives. It involves infusing antibodies obtained from donated blood of recovered patients into those undergoing therapy.

The primary forms of plasma therapy encompass pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). Pure Platelet-Rich Plasma (P-PRP) or leucocyte-poor PRP products are activated preparations lacking leukocytes and possessing a low-density fibrin structure. These varied applications span orthopedics, arthritis, chronic tendinitis, bone repair and regeneration, dermatology, androgenic alopecia, plastic surgery, dental procedures, cardiac muscle injury, among others. These applications find implementation across diverse sectors, including hospitals, clinics, laboratories, and research institutions.

The plasma therapy market research report is one of a series of new reports from The Business Research Company that provides plasma therapy market statistics, including plasma therapy industry global market size, regional shares, competitors with a plasma therapy market share, detailed plasma therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the plasma therapy industry. This plasma therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The plasma therapy market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing awareness of the benefits of plasma therapy, government support for plasma therapy, reimbursement coverage for plasma therapy, increasing demand for minimally invasive procedures, rising demand for personalized medicine, growing geriatric population.

The plasma therapy market size is expected to see rapid growth in the next few years. It will grow to $0.88 billion in 2029 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to increasing adoption of immunoglobulins, expanding applications, rising demand for rare diseases treatment, customized therapies. Major trends in the forecast period include development of new and improved plasma therapy techniques, biological manufacturing, cell-free plasma therapies, telemedicine integration, research into new applications.

The expected surge in osteoarthritis cases is set to drive growth in the plasma therapy market, particularly highlighting Platelet-rich plasma (PRP) as a safe and effective remedy. PRP, through the injection of concentrated autologous blood growth factors into the affected joint, alleviates symptoms by reducing inflammation and slowing osteoarthritis progression. The Journal of Elsevier's September 2023 report forecasts a substantial global increase in osteoarthritis cases by 2050, spanning various joints like the knee, hand, hip, and other types. This projected surge in osteoarthritis incidences is likely to spur demand for plasma therapy, particularly leveraging the efficacy of PRP.

The anticipated increase in cosmetic and aesthetic procedures is likely to boost the plasma therapy market in the future. These procedures encompass medical and surgical methods designed to enhance or restore a person's appearance by modifying physical traits. Plasma therapy, especially in the form of platelet-rich plasma (PRP), is applied in cosmetic and aesthetic treatments to rejuvenate skin, enhance collagen production, and speed up tissue healing. For example, in August 2023, The Aesthetic Society, a US organization focused on plastic surgery and cosmetic medicine, reported that Americans collectively spent over $11.8 billion on aesthetic procedures, marking a 2% rise from the prior year. Thus, the expansion of cosmetic and aesthetic procedures is contributing to the growth of the plasma therapy market.

Major players in the plasma therapy market are trailblazing with innovative products like the ESG-410, addressing evolving needs and diversifying treatment options. Olympus Corporation, in June 2023, launched the ESG-410, an Electrosurgical Generator optimized for treating NMIBC and benign prostatic hyperplasia. This next-gen generator incorporates advanced design elements like improved capacitors, ensuring superior plasma stability during ignition. With rapid ignition and enhanced plasma stability compared to its predecessor, the ESG-400, this generator introduces varied resection loops, electrodes, and vaporization tools, marking significant progress in treating NMIBC and BPH.

Key contributors in the plasma therapy domain are pioneering novel treatment methods, such as the Thulium Laser Non-Surgical Hair Loss Treatment, to meet evolving demands and expand treatment options. Revealed by researchers at Regeneris Medical Boston in August 2022, this innovation harnesses a specific 1,927 nm fractional thulium laser system coupled with growth factors from High-Density platelet-rich plasma (HDPRP) to stimulate hair regrowth without direct scalp injections. This groundbreaking technique utilizes platelet-rich plasma via Thulium Laser Technology, offering a needle-free, non-invasive approach for treating hair loss.

Major companies operating in the plasma therapy market include Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.

North America was the largest region in the plasma therapy market in 2024. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The plasma therapy market includes revenues earned by entities by replacing missing or deficient proteins and developing better means of managing the disease. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Plasma Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on plasma therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for plasma therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The plasma therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Pure PRP; Leukocyte-rich PRP; Pure Platelet-rich Fibrin (PRF); Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopedics; Arthritis; Chronic Tendinitis; Bone Repair & Regeneration; Dermatology; Androgenic Alopecia; Plastic Surgery; Dental; Cardiac Muscle Injury; Other Applications
3) By End-Users: Hospitals & Clinics; Laboratories: Research Institutes
Subsegments:
1) By Pure PRP: High Concentration PRP; Low Concentration PRP
2) By Leukocyte-Rich PRP: PRP With White Blood Cells; PRP With Growth Factors
3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF; Membrane PRF
4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots; L-PRF Membranes
Companies Mentioned: Takeda Pharmaceutical Company Limited; Bio Products Laboratory Ltd.; Arthrex Inc.; Biotest AG; China Biologic Products Holdings Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32954

1. Executive Summary

2. Plasma Therapy Market Characteristics

3. Plasma Therapy Market Trends And Strategies

4. Plasma Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Plasma Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Plasma Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Plasma Therapy Market Growth Rate Analysis
5.4. Global Plasma Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Plasma Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Plasma Therapy Total Addressable Market (TAM)

6. Plasma Therapy Market Segmentation

6.1. Global Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pure PRP
Leukocyte-rich PRP
Pure Platelet-rich Fibrin (PRF)
Leukocyte-rich Fibrin (L-PRF)
6.2. Global Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Orthopedics
Arthritis
Chronic Tendinitis
Bone Repair & Regeneration
Dermatology
Androgenic Alopecia
Plastic Surgery
Dental
Cardiac Muscle Injury
Other Applications
6.3. Global Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals & Clinics
Laboratories
Research Institutes
6.4. Global Plasma Therapy Market, Sub-Segmentation Of Pure PRP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
High Concentration PRP
Low Concentration PRP
6.5. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-Rich PRP, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PRP With White Blood Cells
PRP With Growth Factors
6.6. Global Plasma Therapy Market, Sub-Segmentation Of Pure Platelet-rich Fibrin (PRF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable PRF
Membrane PRF
6.7. Global Plasma Therapy Market, Sub-Segmentation Of Leukocyte-rich Fibrin (L-PRF), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
L-PRF Clots
L-PRF Membranes

7. Plasma Therapy Market Regional And Country Analysis

7.1. Global Plasma Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Plasma Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Plasma Therapy Market

8.1. Asia-Pacific Plasma Therapy Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Plasma Therapy Market

9.1. China Plasma Therapy Market Overview
9.2. China Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Plasma Therapy Market

10.1. India Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Plasma Therapy Market

11.1. Japan Plasma Therapy Market Overview
11.2. Japan Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Plasma Therapy Market

12.1. Australia Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Plasma Therapy Market

13.1. Indonesia Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Plasma Therapy Market

14.1. South Korea Plasma Therapy Market Overview
14.2. South Korea Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Plasma Therapy Market

15.1. Western Europe Plasma Therapy Market Overview
15.2. Western Europe Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Plasma Therapy Market

16.1. UK Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Plasma Therapy Market

17.1. Germany Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Plasma Therapy Market

18.1. France Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Plasma Therapy Market

19.1. Italy Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Plasma Therapy Market

20.1. Spain Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Plasma Therapy Market

21.1. Eastern Europe Plasma Therapy Market Overview
21.2. Eastern Europe Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Plasma Therapy Market

22.1. Russia Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Plasma Therapy Market

23.1. North America Plasma Therapy Market Overview
23.2. North America Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Plasma Therapy Market

24.1. USA Plasma Therapy Market Overview
24.2. USA Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Plasma Therapy Market

25.1. Canada Plasma Therapy Market Overview
25.2. Canada Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Plasma Therapy Market

26.1. South America Plasma Therapy Market Overview
26.2. South America Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Plasma Therapy Market

27.1. Brazil Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Plasma Therapy Market

28.1. Middle East Plasma Therapy Market Overview
28.2. Middle East Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Plasma Therapy Market

29.1. Africa Plasma Therapy Market Overview
29.2. Africa Plasma Therapy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Plasma Therapy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Plasma Therapy Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Plasma Therapy Market Competitive Landscape And Company Profiles

30.1. Plasma Therapy Market Competitive Landscape
30.2. Plasma Therapy Market Company Profiles
- 30.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Bio Products Laboratory Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Arthrex Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Biotest AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Plasma Therapy Market Other Major And Innovative Companies

31.1. DePuy Synthes Companies
31.2. CSL Limited
31.3. Grifols S.A.
31.4. Octapharma AG
31.5. Terumo BCT Inc.
31.6. Pfizer Inc.
31.7. Kedrion Biopharma
31.8. ADMA Biologics Inc.
31.9. SK Plasma Co. Ltd.
31.10. Kamada Ltd.
31.11. Grifols International S.A.
31.12. Fusion HealthCare
31.13. LFB Plasma
31.14. Baxter International Inc.
31.15. Bayer AG

32. Global Plasma Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Plasma Therapy Market

34. Recent Developments In The Plasma Therapy Market

35. Plasma Therapy Market High Potential Countries, Segments and Strategies

35.1 Plasma Therapy Market In 2029 - Countries Offering Most New Opportunities
35.2 Plasma Therapy Market In 2029 - Segments Offering Most New Opportunities
35.3 Plasma Therapy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer